|EXEN -- Israel Stock|| |
ILS 1,019 30.10 3.04%
Analysis of Exalenz Bioscience manpower and management performance can provide insight into Exalenz Bioscience stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Exalenz Bioscience future performance. Additionally see Investing Opportunities
Exalenz Bioscience Management Effectiveness
The company has return on total asset (ROA)
of (31.41) %
which means that it has lost $31.41 on every $100 spent on asset. This is way below average.
Exalenz Bioscience Workforce Comparison
Exalenz Bioscience Ltd is one of the top stocks in number of employees category among related companies. The total workforce
of Diagnostics & Research
industry is currently estimated at about 34.0. Exalenz Bioscience totals roughly 17.0 in number of employees claiming about 50% of equities under Diagnostics & Research industry.
Exalenz Bioscience Profit Margins
The company has Profit Margin (PM) of (35.89) %
which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (38.82) %
which suggests for every $100 dollars of sales it generated a net operating loss of -0.39.
Exalenz Bioscience Stakeholders
Exalenz Bioscience employes about 17 people. The company is managed by 22 executives with total tenure of roughly 110 years, averanging almost 5.0 years of service per executive having 0.0 employee per reported executive.
|Revenue Per Employee||717.6 K|
|Revenue Per Executive||554.5 K|
|Net Loss Per Employee||257.6 K|
|Net Loss Per Executive||199.1 K|
|Working Capital Per Employee||1.5 M|
|Working Capital Per Executive||1.2 M|